Guidelines for Cancer Care during the COVID-19 Pandemic in South Korea
Authors
Jii Bum Lee ; Minkyu Jung ; June Hyuk Kim ; Bo Hyun Kim ; Yeol Kim ; Young Seok Kim ; Byung Chang Kim ; Jin Kim ; Sung Ho Moon ; Keon-Uk Park ; Meerim Park ; Hyeon Jin Park ; Sung Hoon Sim ; Hong Man Yoon ; Soo Jung Lee ; Eunyoung Lee ; June Young Chun ; Youn Kyung Chung ; So-Youn Jung ; Jinsoo Chung ; Eun Sook Lee ; Hyun Cheol Chung ; Tak Yun ; Sun Young Rha
Citation
CANCER RESEARCH AND TREATMENT, Vol.53(2) : 323-329, 2021-04
COVID-19* ; Clinical Trials as Topic ; Early Detection of Cancer ; Humans ; Medical Oncology / standards* ; Neoplasms / therapy* ; Patient Safety ; Practice Guidelines as Topic* ; Republic of Korea
Keywords
COVID-19 ; Cancer care ; Guideline ; Korea
Abstract
At the end of 2019, the cause of pneumonia outbreaks in Wuhan, China, was identified as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In February 2020, the World Health Organization named the disease cause by SARS-CoV-2 as coronavirus disease 2019 (COVID-19). In response to the pandemic, the Korean Cancer Association formed the COVID-19 task force to develop practice guidelines. This special article introduces the clinical practice guidelines for cancer patients which will help oncologists best manage cancer patients during the COVID-19 pandemic.